59-42-7 L-Phenylephrine AKSci J10016
 
 
Loading Please Wait...
  J10016    AKSci Reference Standard
L-Phenylephrine
, >98% (HPLC)
 



IDENTITY
CAS Number:59-42-7
MDL Number:MFCD00044749
MF:C9H13NO2
MW:167.21
EINECS:200-424-8
SPECIFICATIONS & PROPERTIES
Purity:>98% (HPLC)
Spectra:FT-IR, LCMS, HPLC, Polarimetry
Physical Form:White powder
Melting Point:170-174°C
Optical Rotation:-52 ~ -58° (c=5, 1mol/L HCl)
Long-Term Storage:Store at room temperature

BIOLOGICAL INFO
Solubility:Hot Methanol
Application(s):Alpha-1-adrenergic receptor agonist

REVIEW

 In general, alpha1-adrenergic receptors mediate contraction and hypertrophic growth of smooth muscle cells. alpha1-receptors are 7-transmembrane domain receptors coupled to G proteins, Gq/11. Three alpha1-receptor subtypes, which share approximately 75% homology in their transmembrane domains, have been identified: alpha1A (chromosome 8), alpha1B (chromosome 5), and alpha1D (chromosome 20). Phenylephrine appears to act similarly on all three receptor subtypes. All three receptor subtypes appear to be involved in maintaining vascular tone. The alpha1A-receptor maintains basal vascular tone while the alpha1B-receptor mediates the vasocontrictory effects of exogenous alpha1-agonists. Activation of the alpha1-receptor activates Gq-proteins, which results in intracellular stimulation of phospholipases C, A2, and D. This results in mobilization of Ca2+ from intracellular stores, activation of mitogen-activated kinase and PI3 kinase pathways and subsequent vasoconstriction. Phenylephrine produces its local and systemic actions by acting on alpha1-adrenergic receptors peripheral vascular smooth muscle. Stimulation of the alpha1-adrenergic receptors results in contraction arteriolar smooth muscle in the periphery. Phenylephrine decreases nasal congestion by acting on alpha1-adrenergic receptors in the arterioles of the nasal mucosa to produce constriction; this leads to decreased edema and increased drainage of the sinus cavities.

GHS

Pictograms

Signal Word
Warning

Hazard Statements
H302

Precautionary Statements
P264; P270; P301+P312; P330; P501


Current as of June 24, 2019

AKSci Reference Standards are high-purity, low-impurity compounds suitable for use as standards.


Download SDS

CATEGORIES

 APIs and Bioactives > Adrenergic Agonists


PubChem